TheStreet downgraded shares of U.S. Physical Therapy (NYSE:USPH) from a b rating to a c+ rating in a research note issued to investors on Friday.
Several other equities analysts have also recently weighed in on USPH. Zacks Investment Research cut U.S. Physical Therapy from a hold rating to a sell rating in a report on Saturday, July 7th. Cantor Fitzgerald raised their price target on U.S. Physical Therapy from $103.00 to $107.00 and gave the company a neutral rating in a report on Friday. Jefferies Financial Group restated a hold rating and set a $105.00 price target on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Finally, Barrington Research restated a hold rating on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Four analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average price target of $113.67.
Shares of NYSE:USPH traded down $0.74 during trading on Friday, hitting $113.53. 8,549 shares of the company’s stock were exchanged, compared to its average volume of 95,454. The company has a current ratio of 1.93, a quick ratio of 2.06 and a debt-to-equity ratio of 0.26. U.S. Physical Therapy has a 52-week low of $64.45 and a 52-week high of $129.65. The stock has a market capitalization of $1.43 billion, a P/E ratio of 54.58, a P/E/G ratio of 3.95 and a beta of 1.19.
U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.06. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. The firm had revenue of $113.10 million during the quarter, compared to analysts’ expectations of $112.79 million. The business’s quarterly revenue was up 9.8% compared to the same quarter last year. On average, research analysts predict that U.S. Physical Therapy will post 2.54 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 7th. Shareholders of record on Friday, November 9th will be issued a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a yield of 0.81%. The ex-dividend date of this dividend is Thursday, November 8th. U.S. Physical Therapy’s dividend payout ratio is presently 44.23%.
In other news, CEO Christopher J. Reading sold 8,768 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, August 14th. The stock was sold at an average price of $115.57, for a total value of $1,013,317.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Mark J. Brookner sold 2,500 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, September 21st. The stock was sold at an average price of $116.00, for a total value of $290,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 17,518 shares of company stock valued at $2,039,093 in the last 90 days. 2.50% of the stock is currently owned by company insiders.
Institutional investors have recently made changes to their positions in the company. Acadian Asset Management LLC purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $106,000. Harvest Fund Management Co. Ltd purchased a new position in shares of U.S. Physical Therapy in the 3rd quarter worth approximately $190,000. Cambridge Investment Research Advisors Inc. purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $219,000. Itau Unibanco Holding S.A. purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $235,000. Finally, Sawtooth Solutions LLC purchased a new position in shares of U.S. Physical Therapy in the 3rd quarter worth approximately $291,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Article: What does cost of debt say about a company’s financial health?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.